Herodium and Cannabis Company Panaxia Complete Merger

Tel Aviv-listed shelf company Herodium Investments Ltd. has completed its merger with Israel-based medical cannabis products manufacturer Panaxia Pharmaceutical Industries Ltd., Herodium announced Tuesday in a stock exchange filing. The merger, first reported in the beginning of the year, was made possible by a NIS 15 million (approximately $4.25 million) investment round in September.

According to Herodium, Panaxia ended the first half of 2019 with revenues of NIS 5.7 million ($1.63 million), up year-over-year, and a loss of NIS 14.5 million ($4.16 million).